Indolocarbazole Derivative AIC as a c-Myc Ligand
Author Information
Author(s): Kaluzhny Dmitry N., Shchyolkina Anna K., Ilyinsky Nikolay S., Borisova Olga F., Shtil Alexander A.
Primary Institution: Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Hypothesis
Does the indolocarbazole derivative AIC preferentially bind to the G-quadruplex of the c-Myc oncogene promoter?
Conclusion
AIC preferentially binds to the G-quadruplex of the c-Myc promoter, leading to downregulation of c-Myc expression in colon carcinoma cells.
Supporting Evidence
- AIC demonstrated a high potency towards the NCI panel of human tumor cell lines.
- The association constant for AIC:G-c-Myc complex was ~100 times greater than for AIC:c-Myc duplex.
- AIC treatment resulted in a 4-6 times decrease in c-Myc mRNA levels in treated cells.
Takeaway
AIC is a special molecule that can stick to a part of DNA called G-quadruplex, which helps turn off a gene that can cause cancer.
Methodology
The study analyzed the binding interactions of AIC with G-quadruplex DNA structures using UV absorption and fluorescence spectroscopy.
Limitations
The study primarily focuses on in vitro results, and the in vivo effects of AIC need further investigation.
Participant Demographics
Human tumor cell lines, specifically HCT116 colon carcinoma cells.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website